ライフサイエンスコーパス: bethanechol

1 specific beta3 antagonist), propranolol, and bethanechol.

2 ates following intravenous administration of bethanechol, a cholinergic agonist, or intralumenal inst

3 These data suggest that bethanechol acts to decrease CTC fluorescence at the sam

4 Bethanechol also reduced gland duct mucin content in the

5 ion therapy for head and neck cancer include bethanechol and acupuncture.

6 holinergic agents (ACh, nicotine, muscarine, bethanechol and pilocarpine) increased [Ca2+]i.

7 ed gastric relaxation was enhanced following bethanechol and reduced by l-NAME administration, sugges

8 Both bethanechol- and LPS-stimulated intestinal lumenal perfu

9 esponse to direct cholinergic stimulation by bethanechol at 2 days postsympathectomy were increased f

10 e effects of SScIgGs on M(3)-R activation by bethanechol (BeCh), M(3)-R occupancy, and receptor bindi

11 ing doses of the muscarinic receptor agonist bethanechol, but not the nicotinic receptor antagonist m

12 ent with the pro-motility muscarinic agonist bethanechol, but were abolished by systemic administrati

13 EVS applied after pre-contraction with bethanechol caused relaxation of wild type gastric tissu

14 ximal fluorescence loss, however, required a bethanechol concentration three times greater than that

15 Bethanechol depressed this excitation whereas muscarine

16 t with MQC inhibited nicotine-evoked but not bethanechol-evoked secretion.

17 m allografts only generated 23% of the total bethanechol-induced contractile force in vitro compared

18 reatic beta-cells with a muscarinic agonist (bethanechol) led to significantly increased plasma insul

19 CL316243 and isoproterenol inhibited the bethanechol-mediated hypertensive LES.

20 Stimulation with either bethanechol or caerulein resulted in a rapid loss of flu

21 d in UP-LPS-treated TLR4-competent mice, but bethanechol-stimulated contractions were not altered by

22 in neutrophil infiltration and a decrease in bethanechol-stimulated contractions.

23 Spontaneous and bethanechol-stimulated jejunal circular muscle contracti

24 nt 2-deoxy-D-glucose (75 mg kg(-1)), whereas bethanechol-stimulated pancreatic protein output was inh

25 wing the loss of CTC fluorescence induced by bethanechol stimulation.

26 e pronounced when lungs were also exposed to bethanechol to stimulate submucosal gland secretion, whe

27 The fluorescence loss induced by bethanechol was blocked by atropine and was seen at all

28 Bethanechol was used to produce contraction of the smoot

29 l muscle contractions caused by nicotine and bethanechol were similar in segments from P2X2+/+ and P2

30 l muscle contractions caused by nicotine and bethanechol were similar in segments from P2X3+/+ and P2